tbuckley/cabot-search huggingface dataset:
Council on Physical Medicine and Rehabilitation
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The immunoregulatory landscape of human tuberculosis granulomas
Authors: Erin F. McCaffrey, Michele Donato, Leeat Keren, Zhenghao Chen, Alea Delmastro, Megan B. Fitzpatrick, Sanjana Gupta, Noah F. Greenwald, Alex Baranski, William Graf, Rashmi Kumar, Marc Bosse, Christine Camacho Fullaway, Pratista K. Ramdial, Erna Forgó, Vladimir Jojic, David Van Valen, Smriti Mehra, Shabaana A. Khader, Sean C. Bendall, Matt van de Rijn, Daniel Kalman, Deepak Kaushal, Robert L. Hunter, Niaz Banaei, Adrie J. C. Steyn, Purvesh Khatri, Michael Angelo
Journal: Nature Immunology (2022)

Abstract Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However, our understanding of the spatial relationships that control human granulomas is limited. Here, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) to image 37 proteins in tissues from patients with active TB. We constructed a comprehensive atlas that maps 19 cell subsets across 8 spatial microenvironments. This atlas shows an IFN-γ-depleted microenvironment enriched for TGF-β, regulatory T cells and IDO1 + PD-L1 + myeloid cells. In a further transcriptomic meta-analysis of peripheral blood from patients with TB, immunoregulatory trends mirror those identified by granuloma imaging. Notably, PD-L1 expression is associated with progression to active TB and treatment response. These data indicate that in TB granulomas, there are local spatially coordinated immunoregulatory programs with systemic manifestations that define active TB.
In Vivo Function of Flow-Responsive Cis-DNA Elements of eNOS Gene: A Role for Chromatin-Based Mechanisms
Authors: Kyung Ha Ku, Michelle K. Dubinsky, Aravin N. Sukumar, Noeline Subramaniam, Manon Y.M. Feasson, Ranju Nair, Eileen Tran, Brent M. Steer, Britta J. Knight, Philip A. Marsden
Journal: Circulation (2021)

eNOS (endothelial nitric oxide synthase) is an endothelial cell (EC)-specific gene predominantly expressed in medium- to large-sized arteries where ECs experience atheroprotective laminar flow with high shear stress. Disturbed flow with lower average shear stress decreases eNOS transcription, which leads to the development of atherosclerosis, especially at bifurcations and curvatures of arteries. This prototypic arterial EC gene contains 2 distinct flow-responsive cis-DNA elements in the promoter, the shear stress response element (SSRE) and the KLF (Krüppel-like factor) element. Previous in vitro studies suggested their positive regulatory functions on flow-induced transcription of EC genes including eNOS. However, the in vivo function of these cis-DNA elements remains unknown.Insertional transgenic mice with a mutation at each flow-responsive cis-DNA element were generated using a murine eNOS promoter-β-galactosidase reporter by linker-scanning mutagenesis and compared with episomal-based mutations in vitro. DNA methylation at the eNOS proximal promoter in mouse ECs was assessed by bisulfite sequencing or pyrosequencing.Wild type mice with a functional eNOS promoter-reporter transgene exhibited reduced endothelial reporter expression in the atheroprone regions of disturbed flow (n=5). It is surprising that the SSRE mutation abrogated reporter expression in ECs and was associated with aberrant hypermethylation at the eNOS proximal promoter (n=7). Reporter gene silencing was independent of transgene copy number and integration position, indicating that the SSRE is a critical cis-element necessary for eNOS transcription in vivo. The KLF mutation demonstrated an integration site-specific decrease in eNOS transcription, again with marked promoter methylation (n=8), suggesting that the SSRE alone is not sufficient for eNOS transcription in vivo. In wild type mice, the native eNOS promoter was significantly hypermethylated in ECs from the atheroprone regions where eNOS expression was markedly repressed by chronic disturbed flow, demonstrating that eNOS expression is regulated by flow-dependent DNA methylation that is region-specific in the arterial endothelium in vivo.We report, for the first time, that the SSRE and KLF elements are critical flow sensors necessary for a transcriptionally permissive, hypomethylated eNOS promoter in ECs under chronic shear stress in vivo. Moreover, eNOS expression is regulated by flow-dependent epigenetic mechanisms, which offers novel mechanistic insight on eNOS gene regulation in atherogenesis.
Energy metabolism of human hibernating myocardium: Implications for contractile dysfunction Achim M. Vogt, Klaus D. M�ller, Woitek Skwara, Jutta Schaper Christoph Bode, Wolfgang K�bler, Albrecht Els�sser. Dept. Cardiology, Heidelberg University, Heidelberg, Germany, Dept. Cardiology, Freiburg University, Freiburg, Germany
Journal: Journal of the American College of Cardiology (2001)
Sixty seconds on . . . covid-19 and sex
Authors: Mun-Keat Looi
Journal: BMJ (2022)

Let's get it onSteady on there.Although you might have expected rates of sexual activity to have gone up during lockdown, the opposite is the case, judging by the plight of the world's leading condom makers. Nothing for the weekend?So it seems.Karex Berhad, the company that makes one in five condoms sold globally, has seen sales drop by over 40% over the past two years. 1 This despite optimism from its chief executive that the lockdowns of 2020 meant that people having "nothing to do but have sex" and others abstaining from having children during a crisis would fuel "double digit" growth in demand.1 Prem Kumar P. Malaysia's Karex: Covid lockdowns dented condom demand.Nikkei Asia.
Correction to: Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms
Journal: Circulation Research (2021)

An error was discovered in Figure 1A.While generating this figure panel, the authors accidentally duplicated the angiopoietin-1 (Ang-1) Western blot and displayed this data for both Ang-1 and hepatocyte growth factor (HGF).
Cytomegalovirus infection of ApoE knockout mice increases IFNg serum levels, which induce expression of monocyte chemoattractant protein-1 by endothelial cells David Rott, Jianhui Zhu, Mary Susan Burnett, Yi Fu Zhou, Amy Wasserman, Stephen E. Epstein. The Cardiovascular Research Institute, Medstar Research Institute, Washington, DC
Journal: Journal of the American College of Cardiology (2001)
VIENNA
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer
Authors: Marco Spadaccini, Michael J Bourke, Roberta Maselli, Marhieu Pioche, Pradeep Bhandari, Jérémie Jacques, Amyn Haji, Dennis Yang, Eduardo Albéniz, Michal Filip Kaminski, Helmut Messmann, Alberto Herreros de Tejada, Sandro Sferrazza, Boris Pekarek, Jerome Rivory, Sophie Geyl, Shraddha Gulati, Peter Draganov, Neal Shahidi, Ejaz Hossain, Carola Fleischmann, Edoardo Vespa, Andrea Iannone, Asma Alkandari, Cesare Hassan, Alessandro Repici
Journal: Gut (2022)

Objective Endoscopic submucosal dissection (ESD) in a curative intent for submucosa-invasive early (T1) colorectal cancers (T1-CRCs) often leads to subsequent surgical resection in case of histologic parameters indicating higher risk of nodal involvement. In some cases, however, the expected benefit may be offset by the surgical risks, suggesting a more conservative approach. Design Retrospective analysis of consecutive patients with T1-CRC who underwent ESD at 13 centres ending inclusion in 2019 (n=3373). Cases with high risk of nodal involvement (non-curative ESD: G3, submucosal invasion&gt;1000 µm, lymphovascular involvement, budding or incomplete resection/R1) were analysed if follow-up data (endoscopy/imaging) were available, regardless of the postendoscopic management (follow-up vs surgery) selected by the multidisciplinary teams in these institutions. Comorbidities were classified according to Charlson Comorbidity Index (CCI). Outcomes were disease recurrence, death and disease-related death rates in the two groups. Rate of residual disease (RD) at both the previous resection site and regional lymph nodes was assessed in the surgical cases as well as from follow-up in the follow-up group. Results Of 604 patients treated by colorectal ESD for submucosally invasive cancer, 207 non-curative resections (34.3%) were included (138 male; mean age 67.6±10.9 years); in 65.2% of cases, no complete resection was achieved (R1). Of the 207 cases, 60.9% (n=126; median CCI: 3; IQR: 2–4) underwent surgical treatment with RD in 19.8% (25/126), while 39.1% (n=81, median CCI: 5; IQR: 4–6) were followed up by endoscopy in all cases. Patients in the follow-up group had a higher overall mortality (HR=3.95) due to non-CRC causes (n=9, mean survival after ESD 23.7±13.7 months). During this follow-up time, tumour recurrence and disease-specific survival rates were not different between the groups (median follow-up 30 months; range: 6–105). Conclusion Following ESD for a lesion at high risk of RD, follow-up only may be a reasonable choice in patients at high risk for surgery. Also, endoscopic resection quality should be improved. Trial registration number NCT03987828 .
Re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robotic-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008
Authors: Jinna Yao, Henry C.C. Pleass, Howard M.H. Lau
Journal: European Urology (2020)
Tidsskrift for den Norske Laegeforening, Oslo
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
RENAL HEMATURIA OF TELANGIECTATIC ORIGIN.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Nature, London
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Authors: Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, Antonietta Bacchiocchi, Noah Earland, Matthew D. Vesely, Abul Usmani, Brandon E. Turner, Chloé B. Steen, Bogdan A. Luca, Ti Badri, Gunsagar S. Gulati, Milad R. Vahid, Farnaz Khameneh, Peter K. Harris, David Y. Chen, Kavita Dhodapkar, Mario Sznol, Ruth Halaban, Aaron M. Newman
Journal: Nature Medicine (2022)
At Swim-Two-Birds
Authors: Flann O'Brien
Journal: Annals of Internal Medicine (1998)

Academia and Clinic1 June 1998At Swim-Two-BirdsFlann O'BrienFlann O'BrienSubmitted by: Rory O'Connor, MB; Greystones, IrelandAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-11-199806010-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is alcohol? All medical authorities tell us it is a double poison − an irritant and a narcotic poison. As an irritant it excites the brain, quickens the action of the heart, produces intoxication and leads to degeneration of tissues. As a narcotic, it chiefly affects the nervous sytem; blunts the sensibility of the brain, spinal cord and nerves; and, when taken in sufficient quantity, produces death. When alcohol is taken into the system, an extra amount of work is thrown on various organs, particularly the lungs. The lungs, being overtaxed, become degenerated, and this is why so many ... Author, Article, and Disclosure InformationAffiliations: Submitted by: Rory O'Connor, MB; Greystones, Ireland PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byLa traduction au brouillon : une écriture à l'ouvrageMaking sense of N/nonsense in Flann O'Brien's At Swim-Two-Birds and The Third Policeman, a Wittgensteinian perspectiveBibliographieThéâtre et déconstruction du nationalisme irlandais dans Faustus Kelly de Flann O'Brien : « all talk and no play » ?A Mortal Agency: Flann O'Brien's At Swim-Two-Birds 1 June 1998Volume 128, Issue 11Page: 921KeywordsAlcoholicsAlcoholsBrainHeartIntoxicationLungsNervesSpinal cord ePublished: 15 August 2000 Issue Published: 1 June 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Error in Figure
Authors: Srishti Saha, Piyush Nathani, Arjun Gupta
Journal: JAMA Internal Medicine (2021)

to their use. 5If and when PAMORAs are used for OIC prophylaxis (especially in patients with cancer), developing constipation would need a thorough evaluation (history, physical examination, and assessment of accompanying symptoms such as nausea and abdominal pain, as well as other workup, such as laboratory and/or imaging studies) to evaluate biochemical, structural, or other causes of constipation, vs just assuming the constipation is related to OIC.Ongoing long-term PAMORA use in a patient with possible obstruction or a luminal lesion could be dangerous.Naloxegol and naldemedine, 2 PAMORAs, are only approved for use in patients with noncancer-related pain and OIC.PAMO-RAs are also more costly compared with traditional laxatives, and payers often encourage step therapy (ie, a failure of traditional laxatives) before covering PAMORAs.As an example, the cash price of a 3-day supply of oral methylnaltrexone (another PAMORA) at the recommended dose of 450 mg once daily ranges from $206 to $221 on GoodRx.com.Recent studies have demonstrated lower rates of bowel dysfunction and OIC with long-acting opioid/naloxone medication combinations (vs opioid alone), but these formulations are not routinely available and do not qualify as PAMORAs per se. 4,6Ongoing clinical trials are evaluating PAMORAs for preventing OIC (eg, ClinicalTrials.govidentifiers NCT02946580, NCT02977286) and we eagerly await their publication.In summary, PAMORAs are useful agents to treat laxative refractory OIC, but traditional laxatives, which are well tolerated, widely available (often over the counter), and inexpensive agents, remain first-line pharmacologic options for preventing and treating OIC.
Myocardial infarction--home or hospital care.
Authors: R Cooper, L Ford
Journal: BMJ (1976)

The hospitals we need SIR,-The report by Rickard,' based on a detailed and authoritative analysis of the cost-effectiveness of two community hospitals, demonstrates clearly how difficult it is to carry out cost-effective studies that allow valid comparisons to be made between two different kinds of hospital such as community hospitals and district general hospitals.As a result of this study Rickard came to the con- clusion (p 113) that "the cost oftreating medical patients in the Community Hospital . . .exceeded the district general hospital cost" and that "the policy implication of this part of the study is that the experimental community hospital units, as at present administered, are not cost-effective" (my italics).The study
COVID‐19 皮肤症状研究综述
Journal: British Journal of Dermatology (2020)

CoV-2)的病毒引起的感染。于 2019 年 12 月在(中国)武汉首次发现该病毒,随后,它在全世界迅速传播。 尽管 COVID-19 最常见的症状是发热、咳嗽、气短、头痛和肌肉疼痛,但最近已越来越频繁地报道与该疾病相 关的皮肤表现(症状)。在这篇综述文章中,我们通过分析截至 2020 年 4 月 30 日在电子数据库 PubMed、Scopus 和 Web of Science 上发表的文章,收集了 COVID-19 相关皮肤表现的临床数据。 根据皮肤表现的临床外观,主要有 6 种类型:i)荨麻疹皮疹,ii)融合性红斑/斑丘疹/麻疹样皮疹,iii)丘疹样疹,iv) 冻疮样肢端型,v)网状青斑/树枝状青斑样,vi)紫癜性"血管炎"型
Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis
Authors: Y Ichiki
Journal: Hepatology (1997)

T-cell-mediated autoimmune mechanisms are considered to be involved in the pathogenesis of primary biliary cirrhosis (PBC). In the previous study, we identified the immunodominant T-cell epitope on the E2 component of pyruvate dehydrogenase complex (PDC-E2) in patients with PBC who have HLA-DRB4*0101. In this report, we revealed that the frequency of the T cells reactive to the human PDC-E2 163-176 peptide is significantly increased in the peripheral blood of patients with PBC as compared with healthy subjects. We also confirmed that these T cells were all restricted with HLA-DRB4*01 (DR53) by using HLA-DR-transfected L cells. These results together with the evidence that the immunodominant B-cell epitope overlaps with the human T-cell epitope of the PDC-E2 antigen indicate that the T cells reactive to this epitope are closely associated with the pathogenesis of PBC at least in patients who have HLA-DR53. Therefore, we analyzed the T-cell receptor (TCR) Vbeta sequence of the five different T-cell clones and the three T-cell clones derived from three patients with PBC and healthy subjects, respectively, which are reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53. The Vbeta- and the Jbeta-gene usages were diverse among the T-cell clones (Vbeta11-Jbeta1.4, Vbeta8-Jbeta1.2, Vbeta12-Jbeta2.1, Vbeta10-Jbeta1.5, and Vbeta20-Jbeta2.1) in patients with PBC. By contrast, in the third complementarity determining region (CDR3), G was frequently found and GXG or GXS motif was identified in all T-cell clones. Moreover, RGXG motif was found in three clones generated from two patients. In healthy subjects, the Vbeta- and the Jbeta-gene usages were also diverse, and GXG and RGXG motif were found. These results indicate that the T cells may recognize the ligand (the human PDC-E2 163-176 peptide/HLA-DR53 complex) using the limited motif in the CDR3 region and that the design of CDR3-specific immunotherapy would be possible using these motifs. (Hepatology 1997 Sep;26(3):728-33)
Degenerative aortic valve disease as an atherosclerotic process: The correlation between aortic valve calcification and coronary artery calcification Francisco Lopez-Jimenez, David King, Juan C. Londono, Gervasio A. Lamas, Michael Gaziano, Scott Solomon, Arthur S. Agatston. Brigham and Women's Hospital, Harvard medical School and MAVERIC, Boston, MA, Mount Sinai Medical Center, Miami Beach, FL
Journal: Journal of the American College of Cardiology (2001)